To estimate the percentage of HIV-infected individuals who demonstrate the booster effect Throughout study [clinicaltrials_resource:bbf3cf5e1b6c056d596c56fb6dbf0fb1]

To estimate the percentage of HIV-infected individuals who demonstrate the booster effect Throughout study [clinicaltrials_resource:bbf3cf5e1b6c056d596c56fb6dbf0fb1]

All eligible study participants
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:bbf3cf5e1b6c056d596c56fb6dbf0fb1
Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection [clinicaltrials:NCT00000955]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

To estimate the percentage of HIV-infected individuals who demonstrate the booster effect Throughout study [clinicaltrials_resource:bbf3cf5e1b6c056d596c56fb6dbf0fb1]

All eligible study participants
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:bbf3cf5e1b6c056d596c56fb6dbf0fb1
Bio2RDF identifier
bbf3cf5e1b6c056d596c56fb6dbf0fb1
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:bbf3cf5e1b6c056d596c56fb6dbf0fb1
measure [clinicaltrials_vocabulary:measure]
To estimate the percentage of HIV-infected individuals who demonstrate the booster effect
time frame [clinicaltrials_vocabulary:time-frame]
description
All eligible study participants
identifier
clinicaltrials_resource:bbf3cf5e1b6c056d596c56fb6dbf0fb1
title
To estimate the percentage of ...... ooster effect Throughout study
@en
inDataset
type
label
To estimate the percentage of ...... 3cf5e1b6c056d596c56fb6dbf0fb1]
@en